Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) employs angiotensin-
converting enzyme 2 (ACE2) as its receptor for cell entrance, and studies have suggested …

Background The role of the renin–angiotensin–aldosterone system (RAAS) in coronavirus
disease 2019 (COVID-19) is controversially discussed. Severe acute respiratory syndrome …

Background 2019 Novel coronavirus disease (COVID-19) is turning into a pandemic
globally lately. Angiotensin-converting enzyme 2 (ACE2) is identified as an important …

Since angiotensin converting enzyme 2 (ACE2) was identified as the host receptor for
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), speculation has arisen …

Abstract Angiotensin-converting enzyme 2 (ACE2) has been recognized as a potential entry
receptor for SARS-CoV-2 infection. Binding of SARS-CoV-2 to ACE2 allows engagement …

An outbreak of pneumonia caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that started in Wuhan, China, at the end of 2019 has become a global …

Although clinical manifestations of the 2019 novel coronavirus disease pandemic (COVID-
19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) …

Since December 2019, the coronavirus 2019 (COVID-19) pandemic has rapidly spread and
overwhelmed healthcare systems worldwide, urging physicians to understand how to …

SARS-CoV-2 gains cell entry via angiotensin-converting enzyme (ACE) 2, a membrane-
bound enzyme of the “alternative”(alt) renin-angiotensin system (RAS). ACE2 counteracts …

Background: Information about angiotensin II (Ang II), angiotensin-converting enzyme 2
(ACE2), and Ang-(1–7) levels in patients with COVID-19 is scarce. Objective: To …